Presentation TCT 2022 Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Presenter: Shamir Mehta September 19, 2022
Presentation TCT 2022 A Randomised Controlled Trial Assessing the Value of Computed Tomography Cardiac Angiography (CTCA) in Improving Patient Satisfaction and Reducing Contrast Load, Procedural Duration, and Complications in Patients Who Had Previous Bypass Operation (CABG)… Presenter: Daniel Jones September 19, 2022
Presentation TCT 2022 Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial Presenter: Jung-Min Ahn September 19, 2022
Presentation TCT 2022 What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE? Presenter: Eric Secemsky September 19, 2022
Presentation TCT 2022 TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial. Presenter: Tijn Jansen September 19, 2022
Presentation TCT 2022 TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan Presenter: Shinichiro Masuda September 19, 2022
Presentation TCT 2022 The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort Presenter: Charles J. Davidson September 19, 2022
Presentation TCT 2022 Clinical Trial Updates: A Selective Review of What All Operators Should Know Presenter: John Carroll September 18, 2022
Presentation TCT 2022 Clinical Implications of RADIANCE II and Recent Renal Denervation Trials: A Clinician’s Perspective Presenter: Patrick O'Gara September 18, 2022
Presentation TCT 2022 Transformative Changes in Clinical Research: A Futurist’s Viewpoint Presenter: C. Michael Gibson September 18, 2022
Presentation TCT 2022 TCT 7: Invasive Versus Conservative Strategy in Elderly Patients With Non-ST Elevation Myocardial Infarction: A Meta-analysis of Randomized Controlled Trials Presenter: Mahmoud Khalil September 18, 2022
Presentation TCT 2022 Health Equity Issues in Clinical Trials: Can We Accelerate Progress? Presenter: Clyde Yancy September 18, 2022
Presentation TCT 2022 Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials Presenter: Philippe Genereux September 18, 2022
Presentation TCT 2022 TCT 295: Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial Presenter: SHIGETAKA KAGEYAMA September 18, 2022
Presentation TCT 2022 TCT 137: Contribution of plaque composition to the extent of plaque fracture and dissection following drug-coated balloon angioplasty in de novo small vessel disease: an interim report of the TRANSFORM-I trial Presenter: Patrick Serruys September 18, 2022
Presentation TCT 2022 TCT 145: Impact of Technique on Provisional Bifurcation Stent Outcomes in the European Bifurcation Club Left Main Coronary Trial Presenter: Sandeep Arunothayaraj September 18, 2022
Presentation TCT 2022 Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL) Presenter: Sanjit Jolly September 18, 2022
Presentation TCT 2022 The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials Presenter: Azeem Latib September 18, 2022
Presentation TCT 2022 Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial Presenter: ShaoLiang Chen September 18, 2022
Presentation TCT 2022 Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial Presenter: Deepak Bhatt September 18, 2022